| Product Code: ETC12130918 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market Overview |
3.1 Grenada Country Macro Economic Indicators |
3.2 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market - Industry Life Cycle |
3.4 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market - Porter's Five Forces |
3.5 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume Share, By Diagnostic Type, 2021 & 2031F |
3.6 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume Share, By Diagnostic Tool, 2021 & 2031F |
3.7 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume Share, By Testing Method, 2021 & 2031F |
3.8 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about exocrine pancreatic insufficiency (EPI) in Grenada |
4.2.2 Growing prevalence of pancreatic diseases in the region |
4.2.3 Advancements in diagnostic technologies for EPI |
4.3 Market Restraints |
4.3.1 Limited healthcare infrastructure and resources in Grenada |
4.3.2 High cost associated with EPI diagnostic tests |
4.3.3 Lack of skilled healthcare professionals specializing in pancreatic disorders |
5 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market Trends |
6 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market, By Types |
6.1 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market, By Diagnostic Type |
6.1.1 Overview and Analysis |
6.1.2 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume, By Diagnostic Type, 2021 - 2031F |
6.1.3 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume, By Genetic Testing, 2021 - 2031F |
6.1.4 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume, By Blood Tests, 2021 - 2031F |
6.1.5 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume, By Imaging Tests, 2021 - 2031F |
6.1.6 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume, By Fecal Fat Analysis, 2021 - 2031F |
6.2 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market, By Diagnostic Tool |
6.2.1 Overview and Analysis |
6.2.2 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume, By Genetic Screening Kits, 2021 - 2031F |
6.2.3 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume, By Enzyme Activity Tests, 2021 - 2031F |
6.2.4 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume, By MRI and CT Scan, 2021 - 2031F |
6.2.5 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume, By Stool Sample Testing, 2021 - 2031F |
6.3 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market, By Testing Method |
6.3.1 Overview and Analysis |
6.3.2 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume, By PCR and DNA Sequencing, 2021 - 2031F |
6.3.3 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume, By Blood Sampling, 2021 - 2031F |
6.3.4 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume, By Radiology-based Imaging, 2021 - 2031F |
6.3.5 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume, By Enzyme Activity Detection, 2021 - 2031F |
6.4 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume, By Patients with Genetic Disorders, 2021 - 2031F |
6.4.3 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume, By Pancreatic Disease Patients, 2021 - 2031F |
6.4.4 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume, By Healthcare Providers, 2021 - 2031F |
6.4.5 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market Revenues & Volume, By Gastroenterologists, 2021 - 2031F |
7 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market Import-Export Trade Statistics |
7.1 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market Export to Major Countries |
7.2 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market Imports from Major Countries |
8 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market Key Performance Indicators |
8.1 Average time taken for EPI diagnosis in Grenada |
8.2 Adoption rate of new EPI diagnostic technologies in the market |
8.3 Patient satisfaction with EPI diagnostic services in Grenada |
9 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market - Opportunity Assessment |
9.1 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market Opportunity Assessment, By Diagnostic Type, 2021 & 2031F |
9.2 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market Opportunity Assessment, By Diagnostic Tool, 2021 & 2031F |
9.3 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market Opportunity Assessment, By Testing Method, 2021 & 2031F |
9.4 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market - Competitive Landscape |
10.1 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 Grenada Exocrine Pancreatic Insufficiency Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here